A Multiple Ascending Dose Study (MAD) In Healthy Subjects To Evaluate The Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile Of Tecarfarin.

Trial Profile

A Multiple Ascending Dose Study (MAD) In Healthy Subjects To Evaluate The Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile Of Tecarfarin.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Tecarfarin (Primary)
  • Indications Thromboembolism
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 09 Feb 2017 Results published in the Thrombosis and Haemostasis.
    • 31 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top